Tian, Sicheng
Ma, Bingting
Guo, Hongyuan
Chong, Zhenlu https://orcid.org/0000-0001-6195-3452
Gilliland, Theron C. Jr.
Hui, Sean https://orcid.org/0000-0002-9870-6823
Wang, Guojie
Zhang, Yuyi https://orcid.org/0000-0001-5554-3756
Zhou, Jiayue https://orcid.org/0009-0008-2294-1481
Sariol, Alan https://orcid.org/0000-0002-3127-0543
Sun, Xinran
Hu, Yingxin
He, Zhuohao https://orcid.org/0000-0003-1505-8750
Fremont, Daved H. https://orcid.org/0000-0002-8544-2689
Klimstra, William B. https://orcid.org/0000-0003-4506-7842
Diamond, Michael S. https://orcid.org/0000-0002-8791-3165
Xiang, Ye https://orcid.org/0000-0003-0230-9522
Zhang, Rong https://orcid.org/0000-0003-2941-4808
Article History
Received: 5 September 2025
Accepted: 19 May 2026
First Online: 9 June 2026
Competing interests
: M.S.D. is a consultant or on a Scientific Advisory Board for Inbios, IntegerBio, Akagera Medicines, GlaxoSmithKline, Merck, and Moderna. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Moderna. The remaining authors declare no competing interests.